期刊文献+

人乳头瘤病毒基因亚型与宫颈病变的关系 被引量:102

Relationship between human papillomavirus types and cervical diseases
下载PDF
导出
摘要 目的研究不同程度的子宫颈癌前病变者感染HPV的基因亚型,以探讨不同基因型HPV感染的致癌性。方法研究对象系356例宫颈HPV感染的患者。以第二代杂交捕获(HCⅡ)试验检测13种HPV-H,同时采用核酸分子快速杂交基因分型技术进行21种HPV-DNA亚型分析;所有研究对象均行宫颈薄层液基细胞学检测(LCT)及阴道镜下宫颈多点活检。根据细胞与病理学诊断有无宫颈病变及其病变程度分组。①宫颈癌与高度鳞状上皮内瘤变(HSIL)组:包括宫颈浸润癌9例、CINⅢ57例、CINⅡ53例;②低度鳞状上皮内瘤变(LSIL)组:包括CINⅠ112例、HPV感染52例;③正常或炎症组:宫颈细胞与组织学正常或炎症者73例。通过HPV-DNA亚型分布,分析HPV感染基因型与宫颈病变程度的关系。结果HPV-H与宫颈癌变密切相关,本组高度病变以上患者中HPV-H阳性率达98·4%;随着宫颈病变程度加重,HPV-H双重与多重感染有增加趋势,在正常与炎症组、LSIL组与HSIL组中两种以上HPV-H基因型感染者分别占13·7%、17·7%和36·6%,HSIL组明显高于其他两组,差异有显著性(P<0·01);本组HPV亚型感染频度由高到低依次为HPV-16(32·9%)、58(18·8%)、52(16·9%)、18(9·0%)、33(8·2%)、68(7·3%)、11(低危型,6·5%)、31(6·2%)、53(5·6%)、39(5·3%)、CP8304(5·1%)、66(3·9%)、6(2·5%)和51、56、45、35、59、43、44、82等少见型;HPV-16、58、33、52与18型在高度鳞状上皮内瘤样病变(HSIL)中感染率分别为56·4%、19·3%、16·0%、12·6%和8·4%,说明这些亚型致癌性更强;两种HPV-DNA检测技术所获结果,具有很高的一致性。结论本组宫颈病变患者感染HPV型别以16、58、52、18、33较为多见,HPV-16、58、33、52与18型致癌性较强;HPV-DNA分型检测在临床诊断与判断预后上具有重要意义。 Objective To investigate the human papillomavirus (HPV) types detected in patients with non - cancer, pre - cancer and cancer lesions at cervix and to analyze the oneogenesis of the various HPV types. Methods the cervical specimens from 356 patients with HPV infection were collected, Hybrid Capture Ⅱ (HCⅡ) assay was used to detect the 13 HPV-H types, and DNA flow - through hybridization genotyping technique was applied to determine the 21 HPV - DNA types. All of the patients received liquid- based cytology test (LCT) and colposcopy with multiple biopsy. According to the cytological and pathological diagnosis, the patients were. divided into three groups: ① cervical cancer and high - grade squamous intraepithelial lesions (HSIL) group, including 9 cases of invasive cervical cancer, 57 CINⅢ and 53 CINⅡ ; ② low - grade squamous intraepithelial lesions (LSIL) group, including 112 CIN Ⅰ and 52 mere HPV infection; ③ 73 in normal or inflammatory group. 1he relationship between HPV types and different cervical diseases was analyzed. Results HPV - H was tested positive in 98.4% of HSIL patients. In normal or inflammatory, LSIL and HSIL groups, double or multiple HPV- H type infection occurred at 13.7%, 17.7 % and 36.6% respectively, with HSIL group noticeably higher than the other two groups, P 〈 0.01. In this study, the prevalence of HPV types from highest to lowest order were as follow: HPV - 16 (32.9%), 58 (18.8%), 52 (16.9%), 18 (9.0%), 33 (8.2%), 68 (7.3%), 11 (low risk type, 6.5%), 31 (6.2%), 53 (low risk .type, 5.6%), 39 (5.3%), CP8304 (5.1%), 66 (low risktype, 3.9%), 6 (2.5%), and other rare types 51, 56, 45, 35, 59, 43, 44, 82, etc. The infection rates of HPV types 16, 58, 33, 52 and 18 in HSIL were 56.4%, 19.3%, 16.0%, 12.6% and 8.4% respectively. The data from HCⅡ and HPV-DNA genotyping were consistent. Conelusiorm HPV - H is closely associated with cervical cancer. HPV types 16, 58, 52, 18, 33 are more common in cervical disease more oncogenic than other HPV types. HPV - DNA genotyping is of great importance in diagnosis and prognosis of cervical disease.
出处 《中国妇产科临床杂志》 2005年第5期346-350,共5页 Chinese Journal of Clinical Obstetrics and Gynecology
  • 相关文献

参考文献6

  • 1沈艳红,陈凤,黄曼妮,刘彬,王希霞,赵方辉,李淑敏,李楠,吴令英,戎寿德,章文华,任生达,黄瑞德,乔友林.我国山西省子宫颈癌高发区人乳头瘤病毒感染调查[J].中国医学科学院学报,2003,25(4):381-385. 被引量:121
  • 2[2]Anttila A, Pukkala E, Sderman B, et al.Effect of organized screening on cervical cancer incidence and mortality in Finland, 1963-1995: Recent increase in cervical cancer incidence.Int J Cancer, 1999,83:59-65.
  • 3[3]Walboomers JM, Jacobs MV, Manos MM, et al.Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.J Pathol, 1999, 189:12-19.
  • 4[4]Bosch FX, Manos MM, Munoz N, et al.Prevalence of Human Papillomavirus in cervical cancer: a World Perspective.J of the National Cancer Inst, 1995, 87: 796-802.
  • 5[5]Clifford GM,Smith JS,Plummer M,et al.Human papillomavirus types in invasive cancer worldwide:a meta-analysis.Br J cancer,2003,88:63-73.
  • 6[6]Biedermann K, Dandachi N, Trattner M, et al. Comparison of Real-Time PCR Signal-Amplified In Situ Hybridization and Conventional PCR for Detection and Quantification of Human Papillomavirus in Archival Cervical Cancer Tissue. J Clin. Microbiol,2004,42: 3758-376.

二级参考文献17

  • 1李连弟,鲁凤珠,张思维,牧人,孙秀娣,皇甫小梅,孙杰,周有尚,欧阳宁慧,饶克勤,陈育德,孙爱明,薛志福,夏毅.中国恶性肿瘤死亡率20年变化趋势和近期预测分析[J].中华肿瘤杂志,1997,19(1):3-9. 被引量:869
  • 2Clavel C, Masure M, Putaud I, et al. Hybrid Capture-Ⅱ, a new sensitive test for human papiUomavirus detection.Comparison with Hybrid Capture I and PCR results in cervical lesions. J Clin Pathol, 1998, 51(9):737-740.
  • 3Sun XW, Ferenczy A, Johnson D, et al. Evaluation of the Hybrid Capture human papiUomavirus deoxyribonucleic acid detection test. Am J Obstet Gynecol, 1995, 173:1432-1437.
  • 4Levert M, Clavel C, Graesslin O, et al. Human papillomavirus typing in routine cervical smears: results from a series of 3778 patients. Gynecol Obstet Fertil, 2000, 28(10):722-728.
  • 5Solomon D, Schiffman M, Tarone R, et ol. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Nail Cancer Inst, 2001, 93(4):293-299.
  • 6Schneider A, Hoyer H, Lotz B, et al. Screening for high-grade cervical intra-epithelial neoplasia and cancer by testing for high-risk HPV, routine cytology or eolposeopy.Int J Cancer, 2000, 89(6):529-534.
  • 7Clavel C, Masure M, Bory JP, et al. Hybrid Capture Ⅱ-based human papiUomavirus detection, a sensitive test to detect in routine high-grade cervical lesions: a preliminary study on 1518 women. Br J Cancer, 1999, 80(9):1306-1311.
  • 8Clavel C, Masure M, Levert M, et al. H,man papillomavirusdetection by the hybrid capture I1 assay: a reliable test to select women with normal cervical smears at risk for developing cervical lesions. Diagn Mol Pathol, 2000, 9(3):145-150.
  • 9Bosch FX, Manos MM, Munos N, et al. Prevalence of human papillomavirus in cervical cancer:a worldwide perspective. J Natl Cancer Inst, 1995, 87:796-802.
  • 10Woodman CB, Collins S, Winter H, et al. Natural history of cervical human papillomavirus infection in young women:a longitudinal cohorts study. Lancet, 2001, 357(9271):1831-1836.

共引文献120

同被引文献778

引证文献102

二级引证文献841

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部